Your browser doesn't support javascript.
loading
Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells.
Zhu, Chen; Song, Zhili; Wang, Anlai; Srinivasan, Srimathi; Yang, Guang; Greco, Rita; Theilhaber, Joachim; Shehu, Elvis; Wu, Lan; Yang, Zhi-Yong; Passe-Coutrin, Wilfried; Fournier, Alain; Tai, Yu-Tzu; Anderson, Kenneth C; Wiederschain, Dmitri; Bahjat, Keith; Adrián, Francisco J; Chiron, Marielle.
Affiliation
  • Zhu C; Sanofi Oncology, Cambridge, MA, United States.
  • Song Z; Sanofi Oncology, Cambridge, MA, United States.
  • Wang A; Sanofi Oncology, Cambridge, MA, United States.
  • Srinivasan S; Sanofi Oncology, Cambridge, MA, United States.
  • Yang G; Sanofi Oncology, Cambridge, MA, United States.
  • Greco R; Sanofi Oncology, Cambridge, MA, United States.
  • Theilhaber J; Sanofi Oncology, Cambridge, MA, United States.
  • Shehu E; Sanofi Oncology, Cambridge, MA, United States.
  • Wu L; Sanofi Research and Development, Sanofi North America, Cambridge, MA, United States.
  • Yang ZY; Sanofi Research and Development, Sanofi North America, Cambridge, MA, United States.
  • Passe-Coutrin W; Sanofi R&D, Biomarkers and Clinical Bioanalyses, Paris, France.
  • Fournier A; Sanofi R&D, Tumor-Targeted Immuno-Modulation I, Vitry-sur-Seine, France.
  • Tai YT; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
  • Anderson KC; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
  • Wiederschain D; Sanofi Oncology, Cambridge, MA, United States.
  • Bahjat K; Sanofi Oncology, Cambridge, MA, United States.
  • Adrián FJ; Sanofi Oncology, Cambridge, MA, United States.
  • Chiron M; Sanofi Oncology, Cambridge, MA, United States.
Front Immunol ; 11: 1771, 2020.
Article in En | MEDLINE | ID: mdl-32922390

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytotoxicity, Immunologic / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytotoxicity, Immunologic / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: United States Country of publication: Switzerland